chrisvoncsefalvay/vaers-outcomes huggingface dataset:
burning sensation in  mouth,on tongue, inside mouth and up her nose,feet were burning; nerve sensation running down both legs; face was a little swollen; has a rash on [her] face; her throat was going to swell shut; lightening in her mouth; lightening in her legs and feet; This is a spontaneous report from a contactable consumer or other non hcp. A 70-years-old elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8733, expiration date was not reported), via an unspecified route of administration in left arm on 25Mar2021 at 10:30 (at the age of 70-years old) as 1st dose, single dose for COVID-19 immunization. The patient's medical history included an allergy to penicillin and epinephrine, and both of those are in the covid vaccine, she has had it since she was 6. The patient was given a dose back in 1976 when she was having her kids and had a reaction, it knocks her out. The patient was at the dentist office and it has been many years ago, had a reaction and then told the dentist about it and they did a crown and there was a little bit on the piece that you put on the tooth, it was a small bit on the cap, had a sinus infection but she was off the antibiotic by the time before the 2 week mark before her vaccine. The patient just had a check-up and it was good. No relevant family history. The patient's concomitant medications were not reported. The patient did not take any vaccines 4 week prior COVID-19 vaccination and no associated adverse event. No history of all previous immunization with the pfizer vaccine considered as suspect, and No additional vaccines administered on same date of the Pfizer suspect. She specified she was monitored for 30 minutes post-vaccination. On 25Mar2021, several minutes after the injection, she had a burning sensation in her mouth, especially on her tongue, inside her mouth and up her nose, had a nerve sensation running down both legs and her feet were burning, mouth stayed with the burning sensation and her face was a little swollen. She specified the swelling was not affecting her breathing and she then left the vaccination site. She repeated the burning never went away, it is still in her mouth then added now, she has a rash on her face. The patient experienced strong burning sensation in her mouth, tongue, and up her nose, it was like a bolt of lightening, bolt of lightening in her legs and feet. The patient still has the burning in her mouth, after that happened it calmed down about 5 minutes later. She didn't feel like her throat was going to swell shut. About 10 min after that, all of the sudden the caller's feet started burning like a nerve sensation like a jolt down her legs and her feet were burning. She asked if she should get the second dose of the vaccine given her reaction to the first. The outcome for the events was Unknown.  Information about lot/ batch number has been requested.
On3/1/21 a used vial of Pfizer vaccine was reconstituted again with sodium chloride, they were reconstituted in error and patient received diluent only immunization. The immunization administered that day was not effective in providing protection against COVID.   Patient did not have any adverse reaction to the sodium chloride and returned on 3/8/21 to receive the correct dosage of Pfizer vaccine.
This case was reported by a physician and described the occurrence of increased alanine aminotransferase in his wifet who had received hep A vaccine inactivated (Havrix). On an unspecified date in Jan 2004, the pt received the first dose of Havrix. Several months after the administration of the first dose of Havrix, on an unspecified date in 2004, the pt experienced increased levels of alanine aminotransferase and aspartate aminotransferase. The outcome of the events is unk. The reporting physician considered the events to possibly be related to vaccination with Havrix.
This spontaneous report was received from a healthcare professional regarding a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 24-MAY-2016, the patient was vaccinated with improperly stored dose of VAQTA lot # L039659 expiration date: 15-MAR-2017 (dose, strength, and route unknown). The vaccine was exposed to temperature of 33.6 Fahrenheit for 12 hours. Data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pain behind left ear and Bell's Palsy symptoms including partial paralysis of the face.  Anti-viral drugs administered as well as steroid shot.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 25-NOV-2012 the patient was vaccinated with VARIVAX (Merck) (lot #, expiration date and route not reported) instead of ZOSTAVAX (no product confusion, just medication error). No concomitant medications were reported. No adverse event reported. Additional information has been requested.
A swollen, painful lymph node with each injection on top of my left collar bone.; A swollen, painful lymph node with each injection on top of my left collar bone.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 12:00 (at the age of 31-year-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 31-year-old); both as a single dose for COVID-19 immunisation. Medical history included borderline personality disorder, major depressive disorder, generalized anxiety disorder and known allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 06Mar2021 at 00:00, the patient experienced a swollen lymph node and painful lymph node with each injection on top of the left collar bone. After the second injection, the patient had two swollen lymph nodes total, one on top of the other on top of left collar bone. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 30Apr2021, the patient underwent lab tests and procedures which included COVID-19 virus test via nasal swab and the result was negative. The clinical outcome of the events a swollen lymph node and painful lymph node with each injection was resolved on an unknown date in 2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.
This patient was seen for her 15 month WCC. The provider was given the patient's WIR report prior to ordering the vaccines. This was to be the patient's 4th dose of DTaP (INFANRIX). The provider ordered me to give this vaccine. As I looked over the patient's WIR, I did not see this listed as a recommended immunization on the patient's WIR, so I asked the advice of my pod supervisor. She said that she does not go by what is recommended on the WIR, and she told me that since it had been more than 4 weeks from the last dose that she agreed with my provider and told me that it was safe/fine to give the vaccine. It was not until the next day that this showed as invalid on WIR, and I brought it to another provider's attention, who informed me that it was invalid, because the patient had not gotten her vaccines on schedule and that it needed to be 6 months between the 3rd and 4th dose according to the CDC catch up schedule.
I did not have an adverse reaction to the vaccine. In 03/2023, I went to the emergency room and diagnosed with deep vein thrombosis in each lung. I returned to the emergency room on 03/31/2023 as I was weak and dizzy. As of today, I am feeling better gradually. I previously tested positive for COVID-19 in 07/2022 and I was given a reduced version of Paxlovid due to my health issues.
nausea, dizzy, tingling hands, pre-syncopal, waited an additional 15 minutes, resolved.
Not feeling well. Lethargic and febrile for 2 days after vaccine.
The morning after receiving second dose, I awoke with a headache, no strength at all and  no bladder control.  It took me forty five minutes to get out of bed after numerous attempts.  I also experience dizziness, balance issues.  In all honesty, it was as if I had gotten Covid all over again.  I had it in late August and all of September.  The second day after the shot, I experienced lack of strength, but not as bad as the first day, and whole body muscle aches.  The third day after,  was about the same and after that, things started getting a  little better.
At time if immunization, patient was 23 yo G2P1 with history of cesarean section. No pregnancy complications such as gestational diabetes or elevated blood pressure, no IUGR. Her EDD was 12/7/18. She had a normal ultrasound on 11/6/18 with normal growth, AFI 24.4cm. On 11/10/18 she presented to the hospital with complaint of decreased fetal movement, and no cardiac activity was seen. Delivered a stillborn, 2.7 kg male, GA at birth 36w1d. Infant appearance normal.
THE PATIENT RECEIVED THIS COVID BIVALENT VACCINE BOOSTER DOSE 4 DAYS AFTER THE POSTED EXPIRATION DATE OF THE LOT USED. THERE HAVE BEEN NO ADVERSE REACTIONS REPORTED.
J96.00 ACUTE RESPIRATORY FAILURE 4/17/2022 DYSPHAGIA
Covid booster was administered to patient on 3/18/23. It was discovered that the vial of this covid vaccine had expired the evening prior, on 3/27/23.
Left shoulder painful; Whole upper left side painful, armpit shoulder and arm; Whole upper left side painful, armpit shoulder and arm; This is a spontaneous report from a contactable consumer (patient). A 36-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: FA7485), via an unspecified route of administration on arm left on 27Jul2021 (age at vaccination: 36 years) as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient concomitant medications within 2 weeks of vaccination included escitalopram oxalate (LEXAPRO) taken for unspecified indication from an unknown date, cetirizine hydrochloride (ZYRTEC) taken for unspecified indication from an unknown date. On 28Jul2021, the patient experienced Left shoulder painful. Whole upper left side painful, armpit shoulder and arm. No lymph nodes affected. The patient received any treatment for the events was reported as no. Hospitalization Prolonged was reported as no. The events was considered as non-serious. The outcome of the events was not recovered.
This case was reported by a pharmacist via call center representative and described the occurrence of fever in a 71-year-old female patient who received Shingrix (batch number 7X3EJ, expiry date 13th October 2020) for prophylaxis. On 11th August 2018, the patient received the 1st dose of Shingrix. In August 2018, less than a week after receiving Shingrix, the patient experienced fever, headache and chills. On an unknown date, the outcome of the fever, headache and chills were unknown. The reporter considered the fever, headache and chills to be possibly related to Shingrix. Additional details were reported as follows: The health care professional was unsure if the events had resolved. The question that came in was could the patient receive their prescription for Famciclovir after receiving the Shingrix. No additional information was provided.
Information has been received from a health professional concerning a 22 year old female with allergy to CECLOR who on 06-DEC-2006 was vaccinated with a second dose of Gardasil (lot #655619/1427F), in the left deltoid. There was no concomitant medication. on 01-JAN-2007 the patient experienced "faint, sweaty, flushed, nauseated and pain (site). Additional information has been requested.
Information has been received from a registered nurse concerning a 60 year old female with no known allergies or medical history who on 24-APR-2007 was vaccinated SC with a 0.65 ml dose of Zostavax vaccine (lot # 656607/0163U). There was no concomitant medication. On 26-APR-2007 the patient developed an oval-shaped welt at the injection site. No rash was involved. The area was sore, but there were no other symptoms. Unspecified medical attention was sought. No laboratory test were performed. At the time of the report, the patient had not recovered. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/14/2007; 6/22/2007. Follow-up information indicated that the patient was instructed to take BENADRYL and apply warm compreases. subsequently the patient recovered, however the date was unknown, the registered nurse has not heard from the patient since. No additional information is expected.
Client developed emboli in lungs and in a large part of the femoral artery.  Was hospitalized and in ICU for a number of days. Is currently at home on strict bedrest and being monitored with coumadin therapy. 10/28/09 DC summary and hospital records received for dates 9/9/09 to 9/17/09. DC DX: DVT LLE and bilat. PE. Presenting SX: pt. initially c/o back pain and leg pain x2wks seen by chiropractor, pt. seen in ER with dx DVT and PE. Pt. admitted and given anticoag. therapy. Upon DC, pt stable but on bedrest.
administered vaccine to minor Father  reported no reaction to the vaccine. Daughter in good condition; no signs or symptoms of distress reported.
My left arm gets a tingling sensation, like ?pins and needles,? like it is ?falling asleep.? It lasts for several hours then goes away. This has happened to me twice since getting this vaccine, and never happened before getting it.
fever (up to 101.8); mild nausea; slight fatigue; aching joints; runny nose; slight headache; breaking into sweats; injection site pain; This is a spontaneous report received from a non-contactable other healthcare professional. A 46-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176, expiry date: unknown), intramuscular in the right arm, on 13Jan2021 15:15, at single dose, for COVID-19 immunization, in the hospital. Medical history included COVID-19. The patient has no known allergies. There were no concomitant medications. The patient did not receive other medications in two weeks. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK 5730), via an unspecified route of administration in the right arm, on 23Dec2020 at 16:00, for COVID-19 immunization. On 13Jan2021 at 18:00, the patient experienced fever (up to 101.8), mild nausea, slight fatigue, aching joints, runny nose, slight headache, breaking into sweats and injection site pain. The patient did not receive treatment for the events. The patient was not tested for COVID-19 post vaccination. The outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
Received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Date of refrigeration was 07-May-2021  No concomitant medications information was not reported No treatment medications were provided    This case was linked to MOD-2021-363735 (Patient Link).
unauthorized full dose received, not immunocompromised but received a third full dose; This spontaneous case was reported by a patient and describes the occurrence of INCORRECT DOSE ADMINISTERED (unauthorized full dose received, not immunocompromised but received a third full dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (unauthorized full dose received, not immunocompromised but received a third full dose). At the time of the report, INCORRECT DOSE ADMINISTERED (unauthorized full dose received, not immunocompromised but received a third full dose) outcome was unknown.            Patient was not immunocompromised.  No concomitant medications were reported.  Patient received 2 doses of the primary series initially. Patient then got a booster dose however patient  wanted a full dose hence received a third full dose.           No treatment information was provided by the reporter.
shingles to left axilla and left scapula area started 10/8/20 started treatment of Valtrex and prednisone 10/11/20. blisters remain under left axilla with moderate pain, rash to left scapula itching and burning.
7 hours after immunization pt had difficulty breathing, pulse 132, was hyperventalating. BP unstable. Saw the physician on 01/16/2002 for complete pe-no problems.
Came to the ER complaining of weakness and chest pain. Recently discharged on 2/1 for sepsis. Covid was treated with remdesivir on last admission. History HTN, hypotensive this admission, ESRD on HD. Troponin 0.03, Creatinine 7.6, BUN 69
No adverse event occurred or reported at the time of vaccination.  A medication error was realized after given vaccine.   Pt was given Pfizer vaccine for ages 6mths-4yrs old first before diluting the vaccine which is recommended before given the vaccine.
Nausea with vomiting, weakness, cold feeling in arms.  Normal neuro exam.  No visible skin reaction, no wheezing. No specific treatment.
SIDE EFFECTS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for  this case. No concomitant medications were reported. On an unspecified date, the subject experienced side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of side effects was not reported. This report was non-serious.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 05-MAY-2016, the patient was vaccinated with improperly stored VARIVAX (which had a lot # of L042265 and an expiration date of 26-OCT-2017; however, dose, dosage number, route of administration and anatomical location were not reported). Information regarding concomitant therapies was not provided. The vaccines experienced a temperature excursion of 10 F for a time frame of 3 hours and 16 minutes. Reportedly, no previous temperature excursions had occurred and the aforementioned one was called out due to a data logger. Despite being vaccinated with such an improperly stored vaccine, no adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Janssen COVID-19 Vaccine EUA Patient received J&J COVID Vaccine on 3/15/2021 per vaccine card. Patient had an ED Visit on 3/17/2021 for a chief complaint of lightheadedness and was diagnosed with Pneumonia with Chest X-ray showing small bilateral pleural effusions with underlying atelectasis or consolidation. On 4/12/2021, Patient presented to ED as instructed by outside physician for finding of blood clot on CT the morning of 4/12/2021 (Pulmonary emboli at the left upper lobe). The patient had CT scheduled during an office appointment on 4/5/2021. Patient admitted for treatment of pulmonary embolism.
possible serum sickness 7 days after vaccine: Hand itching, angioedema to lips and face, swelling to hands and genitals, urticaria to chest, inner elbows, groin, genitals, extremities, flushing to face
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with the first dose of VARIVAX, dose route and frequency unknown. On 13-OCT-2011 the patient was vaccinated with improperly stored dose of VARIVAX lot # 669601/0138AA, dose number 2. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Patient presented to Health Department 9/21/22 to receive a Pfizer Bi-Valent booster vaccine. Patient was inadvertently administered a Pfizer Mono-Valent vaccine.
The next day after receiving the 1st dose of the Moderna covid vaccine I started experiencing body aches and then a couple hours later I decided to take a nap and I woke up with chills and a fever. The highest my fever got was 102.4 and I had a fever for the rest of the day and into the next morning.
Red, swollen area around where got shot. Received shot 9/1/17 showed me on 9/5/17. She took BENADRYL.